Announcements Trials
Browse Landscape

Phase

Phase 2 21Phase 3 7Phase NA 5Phase 4 1Phase 2/3 1Phase 1 1

Status

Unknown 1

Sponsor Class

INDUSTRY 572OTHER 522NIH 102NETWORK 11FED 4OTHER_GOV 2UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Melanoma 3Stomach Neoplasms 2Rectal Neoplasms 2Neoplasms 2Advanced Cancer 2Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Small Cell Lung Carcinoma 1Ovarian Neoplasms 1Lymphoma 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Advanced Tumor of Digestive Tract or Urinary System 1Adenocarcinoma 1

Interventions

icaritin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × UNKNOWN × Breast Neoplasms × Clear all
NCT01278810 2011-01-28

Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients

ChineseAMS

Phase 1 Unknown
30 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡